|
Alembic Pharmaceuticals Ltd.
|
Balance Sheet
|
|
|
You can view the
Balance Sheet
for the last 5 years.
|
Market Cap. (Rs.)
|
13073.41 Cr.
|
P/BV
|
2.40
|
Book Value (Rs.)
|
277.42
|
|
52 Week High/Low (Rs.)
|
1108/652
|
FV/ML
|
2/1
|
P/E(X)
|
22.41
|
|
Bookclosure
|
29/07/2025
|
EPS (Rs.)
|
29.68
|
Div Yield (%)
|
1.65
|
|
(Rs. in Crs.)
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 2.00 |
| No. of Equity Shares (in Lacs) | 1965.63 | 1965.63 | 1965.63 | 1965.63 | 1965.63 |
| | | | | | |
| EQUITIES AND LIABILITIES | | | | | |
| SHAREHOLDER'S FUNDS | | | | | |
| Equity Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| Total Share Capital | 39.31 | 39.31 | 39.31 | 39.31 | 39.31 |
| | | | | | |
| Reserves and Surplus | 5151.64 | 4778.89 | 4331.16 | 5198.23 | 5088.30 |
| Total Reserves and Surplus | 5151.64 | 4778.89 | 4331.16 | 5198.23 | 5088.30 |
| Total Shareholders Funds | 5190.95 | 4818.20 | 4370.47 | 5237.54 | 5127.61 |
| Minority Interest | -1.42 | 0.00 | 0.00 | 0.00 | -60.64 |
| | | | | | |
| NON-CURRENT LIABILITIES | | | | | |
| Long Term Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 199.89 |
| Deferred Tax Liabilities [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 4.21 |
| Other Long Term Liabilities | 46.77 | 62.88 | 69.23 | 72.14 | 71.54 |
| Long Term Provisions | 124.31 | 109.51 | 106.20 | 95.82 | 85.52 |
| Total Non-Current Liabilities | 171.08 | 172.39 | 175.43 | 167.96 | 361.16 |
| | | | | | |
| CURRENT LIABILITIES | | | | | |
| Short Term Borrowings | 1195.57 | 430.45 | 635.87 | 629.99 | 0.02 |
| Trade Payables | 879.89 | 735.64 | 679.81 | 706.39 | 668.77 |
| Other Current Liabilities | 251.00 | 223.65 | 251.19 | 316.51 | 560.07 |
| Short Term Provisions | 85.87 | 65.25 | 70.06 | 63.64 | 51.99 |
| Total Current Liabilities | 2412.33 | 1454.99 | 1636.93 | 1716.53 | 1280.85 |
| | | | | | |
| Total Capital And Liabilities | 7772.94 | 6445.58 | 6182.83 | 7122.03 | 6708.98 |
| | | | | | |
| ASSETS | | | | | |
| NON-CURRENT ASSETS | | | | | |
| Tangible Assets | 2523.53 | 2546.71 | 2398.45 | 1741.47 | 1703.74 |
| Intangible Assets | 0.00 | 0.00 | 0.00 | 56.38 | 85.55 |
| Capital Work-In-Progress | 837.23 | 524.36 | 601.28 | 2205.79 | 1944.28 |
| Intangible Assets Under Development | 0.00 | 0.00 | 0.00 | 98.44 | 237.39 |
| Fixed Assets | 3360.76 | 3071.07 | 2999.73 | 4102.08 | 3970.96 |
| Non-Current Investments | 127.21 | 93.02 | 96.33 | 118.40 | 49.31 |
| Deferred Tax Assets [Net] | 166.03 | 169.64 | 123.01 | 5.88 | 0.00 |
| Other Non-Current Assets | 31.15 | 33.29 | 53.74 | 34.88 | 110.81 |
| Total Non-Current Assets | 3685.15 | 3367.02 | 3272.81 | 4261.24 | 4131.08 |
| | | | | | |
| | | | | | |
| CURRENT ASSETS | | | | | |
| Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 186.97 |
| Inventories | 2288.14 | 1643.54 | 1475.27 | 1609.70 | 1486.15 |
| Trade Receivables | 1399.79 | 1024.84 | 1046.40 | 807.13 | 348.58 |
| Cash And Cash Equivalents | 90.10 | 126.57 | 82.27 | 69.43 | 105.84 |
| OtherCurrentAssets | 309.76 | 283.61 | 306.08 | 374.53 | 450.36 |
| Total Current Assets | 4087.79 | 3078.56 | 2910.02 | 2860.79 | 2577.90 |
| | | | | | |
| Total Assets | 7772.94 | 6445.58 | 6182.83 | 7122.03 | 6708.98 |
| | | | | | |
| OTHER INFORMATION | | | | | |
| | | | | | |
| CONTINGENT LIABILITIES, COMMITMENTS | | | | | |
| Contingent Liabilities | 189.48 | 183.13 | 317.96 | 228.15 | 349.23 |
| | | | | | |
| NON-CURRENT INVESTMENTS | | | | | |
| Non-Current Investments Unquoted Book Value | 25.72 | 68.61 | 71.20 | 63.69 | 0.45 |
